Data updated: Mar 10, 2026
LAZANDA
FENTANYL CITRATE
Approved 2011-06-30
1
Indication
--
Phase 3 Trials
14
Years on Market
Details
- Status
- Discontinued
- First Approved
- 2011-06-30
- Routes
- NASAL
- Dosage Forms
- SPRAY, METERED
LAZANDA Approval History
Loading approval history...
What LAZANDA Treats
1 FDA approvalsOriginally approved for its first indication in 2011 .
- Other (1)
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
LAZANDA FDA Label Details
ProLAZANDA Patents & Exclusivity
Latest Patent: Jan 2032
Patents (9 active)
US9731869
Expires Jan 26, 2032
Source: FDA Orange Book
Want competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.